Cargando…

Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults

INTRODUCTION: Millions of HIV-infected Africans are living longer due to long-term antiretroviral therapy (ART), yet little is known about glucose metabolism disorders in this group. We aimed to compare the prevalence of glucose metabolism disorders among HIV-infected adults on long-term ART to ART-...

Descripción completa

Detalles Bibliográficos
Autores principales: Maganga, Emmanuel, Smart, Luke R., Kalluvya, Samuel, Kataraihya, Johannes B., Saleh, Ahmed M., Obeid, Lama, Downs, Jennifer A., Fitzgerald, Daniel W., Peck, Robert N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545793/
https://www.ncbi.nlm.nih.gov/pubmed/26287742
http://dx.doi.org/10.1371/journal.pone.0134410
_version_ 1782386785729380352
author Maganga, Emmanuel
Smart, Luke R.
Kalluvya, Samuel
Kataraihya, Johannes B.
Saleh, Ahmed M.
Obeid, Lama
Downs, Jennifer A.
Fitzgerald, Daniel W.
Peck, Robert N.
author_facet Maganga, Emmanuel
Smart, Luke R.
Kalluvya, Samuel
Kataraihya, Johannes B.
Saleh, Ahmed M.
Obeid, Lama
Downs, Jennifer A.
Fitzgerald, Daniel W.
Peck, Robert N.
author_sort Maganga, Emmanuel
collection PubMed
description INTRODUCTION: Millions of HIV-infected Africans are living longer due to long-term antiretroviral therapy (ART), yet little is known about glucose metabolism disorders in this group. We aimed to compare the prevalence of glucose metabolism disorders among HIV-infected adults on long-term ART to ART-naïve adults and HIV-negative controls, hypothesizing that the odds of glucose metabolism disorders would be 2-fold greater even after adjusting for possible confounders. METHODS: In this cross-sectional study conducted between October 2012 and April 2013, consecutive adults (>18 years) attending an HIV clinic in Tanzania were enrolled in 3 groups: 153 HIV-negative controls, 151 HIV-infected, ART-naïve, and 150 HIV-infected on ART for ≥ 2 years. The primary outcome was the prevalence of glucose metabolism disorders as determined by oral glucose tolerance testing. We compared glucose metabolism disorder prevalence between each HIV group vs. the control group by Fisher’s exact test and used multivariable logistic regression to determine factors associated with glucose metabolism disorders. RESULTS: HIV-infected adults on ART had a higher prevalence of glucose metabolism disorders (49/150 (32.7%) vs.11/153 (7.2%), p<0.001) and frank diabetes mellitus (27/150 (18.0%) vs. 8/153 (5.2%), p = 0.001) than HIV-negative adults, which remained highly significant even after adjusting for age, gender, adiposity and socioeconomic status (OR = 5.72 (2.78–11.77), p<0.001). Glucose metabolism disorders were significantly associated with higher CD4+ T-cell counts. Awareness of diabetes mellitus was <25%. CONCLUSIONS: HIV-infected adults on long-term ART had 5-fold greater odds of glucose metabolism disorders than HIV-negative controls but were rarely aware of their diagnosis. Intensive glucose metabolism disorder screening and education are needed in HIV clinics in sub-Saharan Africa. Further research should determine how glucose metabolism disorders might be related to immune reconstitution.
format Online
Article
Text
id pubmed-4545793
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45457932015-09-01 Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults Maganga, Emmanuel Smart, Luke R. Kalluvya, Samuel Kataraihya, Johannes B. Saleh, Ahmed M. Obeid, Lama Downs, Jennifer A. Fitzgerald, Daniel W. Peck, Robert N. PLoS One Research Article INTRODUCTION: Millions of HIV-infected Africans are living longer due to long-term antiretroviral therapy (ART), yet little is known about glucose metabolism disorders in this group. We aimed to compare the prevalence of glucose metabolism disorders among HIV-infected adults on long-term ART to ART-naïve adults and HIV-negative controls, hypothesizing that the odds of glucose metabolism disorders would be 2-fold greater even after adjusting for possible confounders. METHODS: In this cross-sectional study conducted between October 2012 and April 2013, consecutive adults (>18 years) attending an HIV clinic in Tanzania were enrolled in 3 groups: 153 HIV-negative controls, 151 HIV-infected, ART-naïve, and 150 HIV-infected on ART for ≥ 2 years. The primary outcome was the prevalence of glucose metabolism disorders as determined by oral glucose tolerance testing. We compared glucose metabolism disorder prevalence between each HIV group vs. the control group by Fisher’s exact test and used multivariable logistic regression to determine factors associated with glucose metabolism disorders. RESULTS: HIV-infected adults on ART had a higher prevalence of glucose metabolism disorders (49/150 (32.7%) vs.11/153 (7.2%), p<0.001) and frank diabetes mellitus (27/150 (18.0%) vs. 8/153 (5.2%), p = 0.001) than HIV-negative adults, which remained highly significant even after adjusting for age, gender, adiposity and socioeconomic status (OR = 5.72 (2.78–11.77), p<0.001). Glucose metabolism disorders were significantly associated with higher CD4+ T-cell counts. Awareness of diabetes mellitus was <25%. CONCLUSIONS: HIV-infected adults on long-term ART had 5-fold greater odds of glucose metabolism disorders than HIV-negative controls but were rarely aware of their diagnosis. Intensive glucose metabolism disorder screening and education are needed in HIV clinics in sub-Saharan Africa. Further research should determine how glucose metabolism disorders might be related to immune reconstitution. Public Library of Science 2015-08-19 /pmc/articles/PMC4545793/ /pubmed/26287742 http://dx.doi.org/10.1371/journal.pone.0134410 Text en © 2015 Maganga et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Maganga, Emmanuel
Smart, Luke R.
Kalluvya, Samuel
Kataraihya, Johannes B.
Saleh, Ahmed M.
Obeid, Lama
Downs, Jennifer A.
Fitzgerald, Daniel W.
Peck, Robert N.
Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults
title Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults
title_full Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults
title_fullStr Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults
title_full_unstemmed Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults
title_short Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults
title_sort glucose metabolism disorders, hiv and antiretroviral therapy among tanzanian adults
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545793/
https://www.ncbi.nlm.nih.gov/pubmed/26287742
http://dx.doi.org/10.1371/journal.pone.0134410
work_keys_str_mv AT magangaemmanuel glucosemetabolismdisordershivandantiretroviraltherapyamongtanzanianadults
AT smartluker glucosemetabolismdisordershivandantiretroviraltherapyamongtanzanianadults
AT kalluvyasamuel glucosemetabolismdisordershivandantiretroviraltherapyamongtanzanianadults
AT kataraihyajohannesb glucosemetabolismdisordershivandantiretroviraltherapyamongtanzanianadults
AT salehahmedm glucosemetabolismdisordershivandantiretroviraltherapyamongtanzanianadults
AT obeidlama glucosemetabolismdisordershivandantiretroviraltherapyamongtanzanianadults
AT downsjennifera glucosemetabolismdisordershivandantiretroviraltherapyamongtanzanianadults
AT fitzgeralddanielw glucosemetabolismdisordershivandantiretroviraltherapyamongtanzanianadults
AT peckrobertn glucosemetabolismdisordershivandantiretroviraltherapyamongtanzanianadults